Bad Drugs or Big Law Stress? Jury to Decide in Reed Smith Partner's Suicide

, The Am Law Daily

   | 2 Comments

Stewart Dolin, a leader of Reed Smith’s corporate department, committed suicide in 2010. His widow seeks $12 million for his death, alleging it was the result of an antidepressant whose suicidal side effects were covered up by GlaxoSmithKline. The pharmaceutical giant claims that Dolin’s death was the result of an unpleasant work environment.

This premium content is reserved for The Legal Intelligencer subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

  • jasfermariquit

    Learning the system of Superior Trading system helped me in standing up again. I’ve been through my darkest hours, a few months ago. But when I learned their methods and strategies it helped me got up again. Search Superior Trading System to know more.

  • Andrew

    Is it really necessary to be detailing the notes from his reviews on here?

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202781576400

Thank you!

This article's comments will be reviewed.